CGH
ALNY icon

Cleary Gull Holdings’s Alnylam Pharmaceuticals ALNY Stock Holding History

Cleary Gull Holdings’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-73
Closed -$7K – 92
2015
Q4 		$7K Buy
+73
New +$6.77K ﹤0.01% 82

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Cleary Gull Holdings's ALNY Position: Q1 2016 in Review

Cleary Gull Holdings sold out of Alnylam Pharmaceuticals (ALNY) in Q1 2016, closing a stake of 73 shares — an estimated $7K sold.

Cleary Gull Holdings first reported a position in ALNY in Q4 2015 and held it in 1 quarter. The position peaked at $7K in Q4 2015. 254 funds tracked by Wall St. Rank hold ALNY as of Q1 2016.

  • Cleary Gull Holdings reported no remaining Alnylam Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
  • Cleary Gull Holdings sold 73 Alnylam Pharmaceuticals shares in Q1 2016, an estimated $7K.
  • Cleary Gull Holdings first reported a position in Alnylam Pharmaceuticals in Q4 2015 and held it in 1 quarter.
  • Cleary Gull Holdings's Alnylam Pharmaceuticals position peaked at $7K in Q4 2015.
  • 254 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q1 2016.

Based on Cleary Gull Holdings's 13F filing for Q1 2016, filed 9 May 2016.